OX40 agonist mAb
/ Novartis, UT MD Anderson Cancer Center
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 24, 2015
Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer
(clinicaltrials.gov)
- P1; N=44; Recruiting; Sponsor: Providence Health & Services
New P1 trial • Biosimilar • Colorectal Cancer • Oncology
1 to 1
Of
1
Go to page
1